Finally, no significant mutations in the DEK gene have been identified in any clinical populations to date, suggesting that DEK expression, mis-localization, and post-translational modifications are the driving mechanisms by which DEK is associated with diseases such as cancer, neurodegeneration, and auto-immune disorders. Here, DEK is linked to cancer.